Preliminary studies suggest that left atrial appendage (LAA) closure might be beneficial in the prevention of stroke in patients with atrial fibrillation (AF). We evaluated the preliminary clinical efficacy of percutaneous LAA closure using the PLAATO-device (ev3 Endovascular, Inc., North Plymouth, MN) and found that none of the patients suffered from thrombo-embolic events within a time period of 2 years after successful LAA closure. Therefore, we believe that percutaneous closure of the LAA might be a valuable technique for AF patients with contra-indications for or failure of oral anticoagulation to prevent thrombo-embolic events.status: publishe
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoag...
peer reviewedAtrial fibrillation (AF) is the most common clinical arrythmia and can be associated wi...
ObjectivesThese studies were conducted to evaluate the feasibility of percutaneous left atrial appen...
Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the t...
Martin J Swaans, Lisette IS Wintgens, Arash Alipour, Benno JWM Rensing, Lucas V...
AIMS: To investigate the feasibility, safety and efficacy of percutaneous closure for prevention of...
Background/ObjectiveAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is ...
Percutaneous left atrial appendage (LAA) closure can be an alternative to coumadin treatment in pati...
OBJECTIVES: To evaluate patient selection, safety, feasibility, and midterm results of percutaneous ...
International audienceObjectives The French left atrial appendage (LAA) closure registry (FLAAC) aim...
Atrial Fibrillation (AF) is a common arrhythmia with an incidence that is as high as 10% in the elde...
Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with pr...
Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and it is associ...
Ignacio Cruz-Gonzalez,* Juan Carlos Rama-Merchan,* Javier Rodriguez-Collado, Javier Martin-Moreiras,...
Atrial fibrillation (AF) is the most common atrial arrhythmia, with a prevalence of 1-2% in the gene...
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoag...
peer reviewedAtrial fibrillation (AF) is the most common clinical arrythmia and can be associated wi...
ObjectivesThese studies were conducted to evaluate the feasibility of percutaneous left atrial appen...
Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the t...
Martin J Swaans, Lisette IS Wintgens, Arash Alipour, Benno JWM Rensing, Lucas V...
AIMS: To investigate the feasibility, safety and efficacy of percutaneous closure for prevention of...
Background/ObjectiveAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is ...
Percutaneous left atrial appendage (LAA) closure can be an alternative to coumadin treatment in pati...
OBJECTIVES: To evaluate patient selection, safety, feasibility, and midterm results of percutaneous ...
International audienceObjectives The French left atrial appendage (LAA) closure registry (FLAAC) aim...
Atrial Fibrillation (AF) is a common arrhythmia with an incidence that is as high as 10% in the elde...
Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with pr...
Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and it is associ...
Ignacio Cruz-Gonzalez,* Juan Carlos Rama-Merchan,* Javier Rodriguez-Collado, Javier Martin-Moreiras,...
Atrial fibrillation (AF) is the most common atrial arrhythmia, with a prevalence of 1-2% in the gene...
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoag...
peer reviewedAtrial fibrillation (AF) is the most common clinical arrythmia and can be associated wi...
ObjectivesThese studies were conducted to evaluate the feasibility of percutaneous left atrial appen...